| 000 | 01716cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030823.0 | ||
| 008 | 130414s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.08.M.Sc.2012.Is.P | ||
| 100 | 0 | _aIslam Mohamed Salah Eldin Abdelhamid Mannaa | |
| 245 | 1 | 2 |
_aA pharmaceutical study on modified release of certain proton pump inhibitors / _cIslam Mohamed Salah Eldin Abdelhamid Mannaa ; Supervised Ahmed Abdelbary Abdelrahman , Ehab Rasmy Bendas |
| 246 | 1 | 5 | _aدراسة صيدلية على اشكال صيدلية محوره الانطلاق لبعض أدوية مثبطات مضخة البروتون |
| 260 |
_aCairo : _bIslam Mohamed Salah Eldin Abdelhamid Mannaa , _c2012 |
||
| 300 |
_a240P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics | ||
| 520 | _aRabeprazole sodium belongs to Proton pump inhibitors (PPIs) which are chemically degraded in acidic environments . The objective of this work was to obtain a stable delayed release oral dosage form by preparing and comparing between different tablet and capsule formulae and also comparing between different enteric coatings representing different classes | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aDelayed release | |
| 653 | 4 | _aEnteric coatings | |
| 653 | 4 | _aRabeprazole sodium | |
| 700 | 0 |
_aAhmed Abdelbary Abdelrahman , _eSupervisor |
|
| 700 | 0 |
_aEhab Rasmy Bendas , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c42626 _d42626 |
||